Socioeconomic Status Tied to New Diagnosis of Hidradenitis Suppurativa
By Elana Gotkine HealthDay Reporter
WEDNESDAY, May 14, 2025 -- For dermatology patients, neighborhood-level socioeconomic status (nSES) is associated with a new diagnosis of hidradenitis suppurativa (HS), according to a study published online May 14 in JAMA Dermatology.
Aileen Y. Chang, M.D., from the University of California San Francisco School of Medicine, and colleagues conducted a cross-sectional study of patients from dermatology clinics in the University of California San Francisco health system between Aug. 1, 2019, and May 31, 2024, to examine the association of nSES with new HS diagnoses among dermatology patients. The researchers assigned nSES quintiles based on the distribution of nSES index values among census tracts in the San Francisco Bay Area, from quintile 1 (lowest nSES census tracts) to quintile 5 (highest nSES census tracts).
The analyses included 65,766 patients, of whom 0.7 percent had a new HS diagnosis. The researchers found that after adjusting for age, sex, and race and ethnicity, lower-SES neighborhoods had greater odds of a new HS diagnosis (odds ratios for quintile 1, 2, 3, and 4 versus 5: 3.32, 2.25, 1.97, and 1.44, respectively). Among patients residing in lower-SES neighborhoods, greater odds of a new HS diagnosis were seen in race-stratified analyses, although the pattern did not reach statistical significance in all racial and ethnic groups.
"This finding supports the hypothesis that neighborhood-level factors may influence the development of HS," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
BRCA Mutations Linked to Breast Implant Anaplastic Large Cell Lymphoma
WEDNESDAY, June 25, 2025 -- For women with breast cancer (BC), BRCA mutations are associated with increased risk of developing breast implant–associated anaplastic large...
ADA: Orforglipron Reduces Glycated Hemoglobin in Early Type 2 Diabetes
WEDNESDAY, June 25, 2025 -- The oral small-molecule glucagon-like peptide-1 receptor agonist, orforglipron, reduced glycated hemoglobin (HbA1c) over 40 weeks in adults with early...
Paternal Mental Distress Linked to Poorer Offspring Development
WEDNESDAY, June 25, 2025 -- Paternal mental distress is associated with poorer child development, according to a study published online June 16 in JAMA Pediatrics. Genevieve Le...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.